Related by context. All words. (Click for frequent words.) 77 malignant lesions 73 lung nodules 72 thyroid nodules 71 microcalcifications 70 benign lesions 67 mammographically 67 mammographic 67 pulmonary nodules 67 neoplasms 67 malignant nodules 66 renal tumors 66 adenomatous polyps 65 hamartomas 65 adenoma 65 neoplasm 65 SLNB 65 supratentorial 65 breast biopsies 65 fibroadenomas 65 axillary dissection 65 advanced adenomas 65 metastatic lesions 65 EUS FNA 65 renal cell carcinomas 64 hamartoma 64 atypical hyperplasia 64 sentinel nodes 64 contralateral breast 64 axillary lymph nodes 64 malignant prostate 64 sonographic findings 64 lung lesions 64 excisional biopsy 64 invasive carcinoma 64 micro calcifications 64 fine needle aspiration 64 lymph node metastases 64 breast lumps 64 PCa 64 lobular carcinoma 64 breast carcinomas 64 breast tumors 64 schwannomas 64 pulmonary metastases 64 Computed Tomography CT scans 64 carcinoid tumor 64 sentinel lymph nodes 63 thyroid nodule 63 endometrial cancers 63 adnexal mass 63 hyperplastic 63 lymph node involvement 63 prostate cancer CaP 63 nodal metastases 63 adnexal masses 63 calcifications 63 leiomyomas 63 colorectal polyps 63 malignant ovarian 63 fibroadenoma 63 breast carcinoma 63 FDG-PET/CT 63 micrometastases 63 lipomas 62 nodal metastasis 62 adenomatous 62 osteoid 62 DCIS lesions 62 varicoceles 62 incidentalomas 62 paragangliomas 62 malignant polyps 62 benign growths 62 ASCUS 62 precursor lesions 62 glandular tissue 62 colonic polyps 62 cervical lesions 62 catheter angiography 62 mucinous 62 carcinoid 62 seminomas 62 ultrasonographic 62 extracapsular extension 62 lesions 62 cytologic 62 ductal carcinomas 62 sonographic appearance 62 colorectal neoplasms 62 sonographically 62 lymph node metastasis 62 core needle biopsy 62 osteosarcomas 62 FDG uptake 62 axillary node dissection 61 ovarian tumors 61 atypia 61 epithelial ovarian cancer 61 benign polyps 61 sentinel lymph node 61 proximal colon 61 transesophageal echocardiography 61 pelvic ultrasound 61 CIN2 + 61 malignant lesion 61 advanced neoplasia 61 cervical lymph nodes 61 mediastinal lymph nodes 61 lung nodule 61 nonmelanoma skin cancers 61 histologic examination 61 carcinomas 61 hyperplastic polyps 61 surgical biopsy 61 histopathologic 61 papillary 61 malignant growths 61 histologically 61 metastases 61 ductal cancer 61 Computed tomography 61 prostate tissue 61 transrectal ultrasound guided 61 benign nodules 61 adrenal masses 61 urine cytology 61 metastatic lymph nodes 61 carotid stenosis 61 colonography 61 urothelial carcinoma 61 Sjögren syndrome 61 immunohistochemical staining 61 adenocarcinomas 61 biopsies 61 epithelial tumors 61 adenomas 61 malignancy 60 tumors 60 GISTs 60 thyroid carcinoma 60 lung tumors 60 neoplastic 60 gadolinium enhanced 60 polypoid 60 sonographic 60 breast tissue 60 pre cancerous polyps 60 microbleeds 60 premalignant 60 Papillary 60 prognostic significance 60 polypoid lesions 60 plain radiographs 60 echogenicity 60 morphologic 60 neoplasias 60 thyroglobulin 60 preoperative diagnosis 60 histological diagnosis 60 needle biopsies 60 tumoral 60 pituitary adenomas 60 meningiomas 60 basal cell carcinoma BCC 60 brain lesions 60 fibrocystic 60 neoplasia 60 cTnT 60 transurethral resection 60 ductal breast cancer 60 lymphadenopathy 60 metastatic tumors 60 atherosclerotic lesions 60 cervical carcinoma 60 preoperative staging 60 Hurthle cell 60 pigmented skin lesions 60 choroidal melanoma 60 ovarian malignancy 59 extracolonic findings 59 Adenomas 59 Doppler sonography 59 axillary lymph node 59 transvaginal sonography 59 ependymomas 59 diagnostic modality 59 scintigraphic 59 tumor subtypes 59 pathologic diagnosis 59 distant metastases 59 ovarian tumor 59 endometrial carcinoma 59 malignant lymph nodes 59 ADPKD 59 calcified plaques 59 B7 H3 59 situ LCIS 59 infarcts 59 chest radiographs 59 lymphovascular invasion 59 #F FDG PET 59 surgical biopsies 59 urothelial cancer 59 metachronous 59 pre malignant lesions 59 PET CT scans 59 malignant tissue 59 cancerous polyps 59 carcinoma 59 melanomas 59 HER2 amplification 59 noncancerous cells 59 advanced adenoma 59 microscopic hematuria 59 kidney cysts 59 cystic lesions 59 testicular tumors 59 colorectal carcinoma 59 Colon polyps 59 pathologic examination 59 lobular carcinomas 59 osteoid osteoma 59 prostate cancers 59 computed tomographic 59 ductal 59 serous ovarian cancer 59 lobular cancer 59 echogenic 59 intestinal metaplasia 59 wedge resection 59 colonoscopic 59 HGPIN 59 leiomyoma 59 neurofibromas 59 cancerous lumps 59 T2 weighted images 59 arthrography 59 T1 weighted 59 sentinel node 59 histological subtype 59 node metastases 59 hypoechoic 59 micrometastasis 59 prostate cancer PCa 59 axillary lymph node dissection 59 mammographic density 59 neoplastic lesions 59 gynecologic malignancy 59 ductal lobular 59 colorectal polyp 59 subclinical hyperthyroidism 59 NP CRNs 59 cerebral microbleeds 59 adrenalectomy 59 endoscopic ultrasonography 59 histologic subtype 59 angiography CTA 58 precancerous polyp 58 squamous 58 lymph node removal 58 teratoma 58 BRCA1 mutation carriers 58 BSGI 58 nodule 58 lesion 58 PSADT 58 HG PIN 58 peritoneal carcinomatosis 58 histopathologic examination 58 bladder cancers 58 gastric adenocarcinoma 58 cancerous lesions 58 chromosomal aberrations 58 mesenteric 58 needle aspiration 58 melanoma tumors 58 nodular melanoma 58 clinicopathologic 58 benign breast 58 varicocele 58 papillary carcinoma 58 liver metastasis 58 BRCA mutations 58 malignant lymphoma 58 neurofibroma 58 tumor histology 58 lymphatic tissue 58 BRCA1 mutations 58 ALCL 58 prostate biopsy 58 Uterine fibroids 58 HER2 overexpression 58 histologic findings 58 computed tomography scans 58 malignant neoplasm 58 pancreatic adenocarcinoma 58 radical nephrectomy 58 hypervascular 58 tissue biopsies 58 parathyroid 58 HER2 positive tumors 58 T1 weighted images 58 prostatic tissue 58 neoplastic cells 58 lung metastases 58 denser breasts 58 thoracoscopic lobectomy 58 precancers 58 melanoma lesions 58 premalignant lesions 58 histopathologic findings 58 prostate carcinoma 58 optical colonoscopy 58 MGUS 58 molecular abnormalities 58 pleomorphic 58 sonographically guided 58 grade gliomas 58 pelvic lymph nodes 58 perfusion abnormalities 58 pCR 58 retroperitoneal 58 HER2 expression 58 anal lesions 58 pre cancerous lesion 58 pancreatic cysts 58 sentinel lymph node biopsy 58 estrogen receptor ER 58 acute aortic dissection 58 precancerous cervical 58 lung adenocarcinomas 58 ductal carcinoma 58 immunohistochemical 58 coronary artery stenosis 58 colposcopic 58 FDG PET 58 submucosal 58 normal karyotype 58 imaging MRI 58 fibroma 58 HRCT 58 core needle biopsies 58 nodules 58 conventional colonoscopy 58 breast cancers 58 bone scintigraphy 58 prostate adenocarcinoma 57 cytoreductive surgery 57 axillary nodes 57 ovarian carcinoma 57 Radical prostatectomy 57 computed tomography CT angiography 57 polyps 57 renal artery stenosis 57 endometrial hyperplasia 57 choroidal neovascularization 57 transfusion syndrome 57 intraepithelial 57 abnormal cytology 57 distant metastasis 57 axilla 57 histopathological 57 eccrine 57 nonmelanoma 57 prostate carcinomas 57 Polyps 57 microdissected 57 chromosomal rearrangement 57 colorectal cancer CRC 57 dysplastic 57 intraoperative complications 57 hepatic lesions 57 grade squamous intraepithelial 57 duplex ultrasonography 57 urethral stricture 57 BRCA2 mutation carriers 57 proton MR spectroscopy 57 basal cell cancers 57 Coronary artery calcium 57 immunostaining 57 carcinomatosis 57 precancer 57 invasive ductal carcinoma 57 metaplasia 57 CIN3 57 keloid 57 Fine needle aspiration 57 underwent resection 57 uveal melanoma 57 angiographically 57 heterotopic bone 57 prostate tumors 57 subclinical atherosclerosis 57 F FDG PET 57 operable breast cancer 57 radiographic findings 57 invasive ductal 57 histological subtypes 57 LVNC 57 prostatic 57 paraganglioma 57 cystoscopic 57 coronary stenoses 57 percutaneous biopsy 57 pituitary adenoma 57 grade dysplasia 57 digital rectal examination 57 pre cancerous lesions 57 liver metastases 57 TOP2A 57 Imaging BSGI 57 epithelial ovarian 57 EBUS FNA 57 monoclonal gammopathy 57 pulmonary angiography 57 differentiated thyroid 57 hepatocellular carcinomas 57 cervical neoplasia 57 thermogram 57 HNSCC 57 upper endoscopy 57 lymphatic mapping 57 sCJD 57 coronary stenosis 57 lung metastasis 57 biopsied tissue 57 DNA methylation patterns 57 called elastography distinguished 57 rebleeding 57 pre cancerous growths 57 acetabular fractures 57 nondiagnostic 57 molecular subtypes 57 carcinoids 57 chest radiograph 57 locoregional recurrence 57 BSGI MBI 57 grade cervical intraepithelial 57 Preoperative 57 helical CT 57 detecting polyps 57 Magnetic resonance imaging 57 melanocytic lesions 57 gene amplification 57 polycystic ovarian syndrome PCOS 57 tumor recurrence 57 cutaneous lesions 57 esophagogastric junction 57 biopsy specimens 57 EGFR mutations 57 osteochondromas 57 HER2 positive cancers 57 choroid 57 hyperintense lesions 57 CIN2 57 needle biopsy 57 FDG PET scans 57 biochemical abnormalities 57 haematuria 57 surgical excision 57 myomas 57 liver parenchyma 57 histologic diagnosis 56 sentinel node biopsy 56 varices 56 KRAS mutations 56 abnormalities 56 nodular 56 tracer uptake 56 Barrett mucosa 56 anaplastic 56 anatomic structures 56 malignant tumors 56 parenchyma 56 endoscopic ultrasound 56 biochemical recurrence 56 obstructive coronary artery 56 axillary 56 enhanced sonography 56 cardiac computed tomography 56 aneuploidies 56 seminal vesicle invasion 56 ischemic lesions 56 intestinal polyps 56 pericardial effusion 56 transthoracic 56 breast endometrial 56 radical prostatectomy RP 56 invasive coronary angiography 56 aerodigestive tract 56 nodal dissection 56 polyps growths 56 Sentinel lymph node 56 Immunohistochemistry 56 urography 56 pathologic 56 thrombi 56 prognostic biomarker 56 IgA deficiency 56 nevus 56 hematopoietic cancers 56 atypical ductal hyperplasia 56 invasive carcinomas 56 neuroendocrine tumors 56 situs inversus 56 coronary vessels 56 hematuria 56 cancerous enlargement 56 BRCA mutation 56 mammary cancers 56 brain parenchyma 56 Ultrasonography 56 cancerous tissue 56 sonographic examination 56 transrectal ultrasound 56 vestibular schwannomas 56 resected 56 serum PSA 56 PTEN mutations 56 osteopenic 56 benign moles 56 scintigraphy 56 ALND 56 Lymph node 56 metastatic lesion 56 Thyroid nodules 56 trabecular bone 56 atrophic gastritis 56 repigmentation 56 osteochondroma 56 postoperative pathology 56 perimenopausal women 56 nephron sparing surgery 56 Plain radiographs 56 PNET 56 tumor biopsies 56 cutaneous melanoma 56 Heavy menstrual bleeding 56 mediastinal 56 bowel cancers 56 F FDG uptake 56 plexiform neurofibromas 56 melanocytic 56 pT2 56 Doppler echocardiography 56 prostatic hyperplasia 56 ipRGCs 56 diabetes mellitus DM 56 chromosomal mutations 56 chromosomal anomalies 56 transabdominal 56 abnormal Pap smears 56 situ DCIS 56 coronary computed tomography 56 chemoembolization 56 ultrasound elastography 56 immunohistochemical analysis 56 invasive lobular carcinoma 56 response pCR 56 aortic atherosclerosis 56 N. gonorrhoeae 56 SUVmax 56 TRUS 56 lobular breast cancer 56 endosonography 56 prostate TURP 56 MR imaging 56 metastatic melanomas 56 squamous cell cancers 56 cerebellar vermis 56 Recurrences 56 squamous cell carcinomas 56 MR spectroscopy 56 benign tumors 56 EBUS 56 molar pregnancy 56 lymphadenectomy 56 intraobserver 56 Magnetic resonance 56 abnormal mammogram 56 Breast Specific Gamma 56 calculi 56 progesterone receptor PR 56 pilocytic astrocytomas 56 Positron emission tomography PET 56 florbetaben 56 conventional angiography 56 Sonographic 56 cerebral angiography 56 polyp detection 56 underarm lymph nodes 56 prophylactic cranial irradiation 56 EGF receptors 56 follicular thyroid cancer 56 pelvic lymphadenectomy 56 multidetector row 56 thyroid hormone levels 56 malignancies 56 hyperechoic 56 mammary cells 56 invasive angiography 56 histologic 56 #F FDG 56 occult metastases 56 sarcomatoid 56 lobular 56 bronchogenic carcinoma 56 Radiofrequency ablation 56 Endometrial cancer 56 dysplasia 56 colorectal adenoma 56 stratifying patients 56 intracranial tumors 56 recurrent ovarian 56 deCODE BreastCancer TM 56 polycystic ovary syndrome PCOS 56 urinary symptoms 56 extracranial 56 vascular abnormalities 56 oncogenic HPV types 56 FDG PET imaging 56 explants 56 colorectal tumors 56 fibrocystic disease 56 abdominal computed tomography 56 mediastinum 56 cytological 56 papillary thyroid carcinoma 56 gynecologic procedures 56 BRCA mutation carriers 56 parenchymal 56 Basal cell carcinoma 56 endobronchial 56 diffusion MRI 56 hypervascular tumors 56 amyloid deposition 56 perfusion defects 56 meniscal tears 56 diskectomy 56 artery stenosis 55 carotid plaque 55 echogenic foci 55 ultrasonographic examination 55 PSA nadir 55 Mammographic 55 pT3 55 coronary plaques 55 Positron emission tomography 55 Computed tomographic 55 mesothelial cells 55 lymphoid cells 55 axillary node 55 clinically localized prostate 55 gastric carcinomas 55 pCLE 55 poorer prognosis 55 K ras mutations 55 histologic subtypes 55 T1a 55 imaging modality 55 prenatal ultrasound 55 papillomas 55 dysplastic nevi 55 arterial calcification 55 EBRT 55 androgen deficiency 55 noncancerous tumors 55 MR arthrography 55 Biopsies 55 somatic mutations 55 ALK mutations 55 mammary tumors 55 immunocompetent 55 precancerous spots 55 noncancerous 55 colorectal gastric 55 BI RADS 55 microvessels 55 noncalcified 55 DCIS 55 methylation patterns 55 screening mammogram 55 Melanomas 55 skeletal metastases 55 pheochromocytoma 55 fibrocystic changes 55 microsatellite instability 55 gastric cardia 55 bowel polyps 55 lipoma 55 splenic 55 vascularity 55 aneuploid cells 55 BRCA2 carriers 55 serrated polyps 55 troponins 55 plexiform 55 fundus 55 cancerous tissues 55 intraductal 55 underwent brachytherapy 55 noncardiac 55 pancreatic lung 55 electrophysiologic 55 gastric carcinoma 55 Doppler ultrasonography 55 carotid IMT 55 gene rearrangements 55 artery blockages 55 immunoreactivity 55 basal cell cancer 55 myeloproliferative diseases 55 computed tomography angiography 55 thyrotoxicosis 55 neuroendocrine carcinoma 55 radioiodine therapy 55 precancerous tumors 55 pleural fluid 55 computerized tomography scans 55 completely resected 55 pseudoaneurysm 55 T2 weighted MRI 55 lymph node dissection 55 endometrioid 55 nonproliferative 55 hyperplasia 55 thoracic aortic aneurysm 55 polyposis 55 malignant neoplasms 55 adrenocortical 55 basal cell carcinomas 55 endoscopic resection 55 noninvasive imaging 55 Capsule endoscopy 55 dysplastic lesions caused 55 infiltrative 55 transrectal ultrasonography 55 esophageal carcinoma 55 NSCLC tumors 55 POAG 55 coronary angiography 55 bilateral oophorectomy 55 neuroblastomas 55 Malignant tumors 55 NPM1 mutation 55 contralateral breast cancer 55 metastatic prostate cancer 55 bronchoalveolar lavage BAL 55 TKAs 55 hyperintensity 55 fetal echocardiography 55 Fibroid tumors 55 systemic lupus erythematosus SLE 55 mesotheliomas 55 invasive diagnostic 55 BRCA gene mutation 55 Doppler ultrasound 55 renal carcinoma 55 lymph nodes 55 dysplastic lesions 55 hydronephrosis 55 sonographic diagnosis 55 resonance imaging 55 Gynecomastia 55 breast MRIs 55 abnormal mammograms 55 Sonography 55 urolithiasis 55 peritoneal cancer 55 trophoblasts 55 T2DM 55 positron emission 55 pancreatic tumors 55 cystic mass 55 CT coronary angiography 55 adrenal cortex 55 myocardial viability 55 underwent radical prostatectomy 55 FGFR2 gene 55 Histologically 55 pathogenic mutations 55 prophylactic mastectomy 55 endometrial biopsy 55 carotid plaques 55 lung carcinomas 55 cystoscopy 55 adnexal 55 Prenatal diagnosis 55 nonalcoholic steatohepatitis NASH 55 CT angiography CTA 55 Mohs surgery 55 microdeletions 55 hypoperfusion 55 cancerous breast 55 prostate abnormalities 55 Basal cell carcinomas 55 cellularity 55 liposarcoma 55 dimensional ultrasonography 55 BRAF mutation 55 basal cell nevus syndrome 55 atypical moles 55 troponin T 55 endometrial 55 SPECT CT imaging 55 GH deficiency 55 bladder tumors 55 fundus photography 55 PCNSL 55 intima media thickness 55 Abdominal ultrasound 55 medullary thyroid cancer 55 colon rectal 55 GBM tumors 55 MSCT 55 Multidetector CT 55 adrenal function 55 fetal aneuploidy 55 ductal adenocarcinoma 55 diffusion tensor 55 neuroendocrine cancers 55 Hemangiomas 55 PIB PET 55 hormone receptor status 55 lung cancers 55 elevated CRP 55 GIST tumors 55 Cystoscopy 55 nephrogenic 55 Doppler imaging 55 oncologic outcomes 54 bone erosions 54 subconjunctival hemorrhage 54 armpit lymph nodes 54 penetrance 54 resectable 54 coronary calcification 54 denervation 54 spectroscopic technique 54 clinically insignificant 54 chlamydial infection 54 aortic insufficiency 54 prophylactic mastectomies 54 sonography 54 carcinoid tumors 54 infiltrating ductal carcinoma 54 HbF 54 hippocampal atrophy 54 adenomyosis 54 specific antigen PSA 54 tumor xenografts 54 spinal metastases 54 salpingo oophorectomy 54 stenoses 54 adjuvant therapies 54 prognostic variables 54 pre cancerous 54 VEGF expression 54 LQTS 54 hypointense 54 NMIBC 54 biliary stones 54 prognostic markers 54 hyperalgesia 54 mediastinoscopy 54 ruptured aneurysms 54 thyrotropin levels 54 breast cancer subtypes 54 malignant phenotype 54 CT angiography 54 myocardial perfusion 54 cervical biopsies 54 Acoustic neuromas 54 #F fluorodeoxyglucose 54 colorectal liver metastases 54 color Doppler ultrasound 54 inherited mutations 54 Multiple logistic regression 54 pancreatic carcinoma 54 skin lesion 54 perioperative complications 54 neurologic symptoms 54 hirsutism 54 seminoma 54 cystectomy 54 beta1 integrin 54 seborrheic keratoses 54 Adjuvant chemotherapy 54 prostate bladder 54 hyperoxaluria 54 sporadic ALS 54 locoregional 54 schwannoma 54 computed tomography CT scan 54 appendiceal 54 dentinal hypersensitivity 54 metastatic disease 54 OGG1 54 genetic polymorphisms 54 Gliomas 54 RVOT 54 transcranial Doppler 54 ascites 54 MALT lymphoma 54 biodistribution 54 computed tomography scan 54 undergoing radical prostatectomy 54 abnormal pap smears 54 chromosomal abnormalities 54 Tumours 54 ventricular myocardium 54 microvessel density 54 CaP 54 myometrium 54 flurpiridaz F 54 untreated celiac disease 54 LTBI 54 anti JCV antibodies 54 luminal 54 opacification 54 DXA scan 54 cell carcinomas 54 metastatic cancer 54 bone metastasis 54 pulmonary metastasis 54 micronuclei 54 malignant tissues 54 cystic 54 partial nephrectomy 54 prostate biopsies 54 postoperative complication 54 HIV HCV coinfected 54 anogenital 54 neurologic complications 54 glioma tumors 54 Endoscopic ultrasound 54 vesicoureteral reflux VUR 54 PrPSc 54 hypopigmentation 54 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 54 prostate cancer metastases 54 microvessel 54 vesicoureteral reflux 54 pelvic malignancies 54 Synovial sarcoma 54 intracranial aneurysms 54 colorectal adenocarcinoma 54 atypical lobular hyperplasia 54 prostate tumor 54 malignant cancerous 54 ultrasonography 54 metastatic prostate 54 thyroid dysfunction 54 cisplatin resistant 54 cardiac troponin 54 radiotracer 54 #.#ng/ml 54 preoperative chemotherapy 54 X ray angiography 54 invasive lobular 54 pulmonary infiltrates 54 LUTS 54 cancerous growths 54 neoadjuvant chemotherapy 54 gynaecomastia 54 subclinical disease 54 lymph node 54 multivariate logistic regression 54 anterior uveitis 54 GnRH agonists 54 Virtual colonoscopy 54 serum PTH 54 neovascularization 54 underwent coronary angiography 54 Digital Mammographic Imaging 54 CT colonography 54 Duodenal 54 Fibroids 54 T2 lesions 54 hypertrophic scars 54 nonmelanoma skin cancer 54 hereditary breast cancer 54 invasive ductal breast cancer 54 urinary cytology 54 thymectomy 54 colorectal neoplasia 54 gastric cancers 54 Cysts 54 thymoma 54 invasive cervical cancer 54 vaginal lesions 54 MDCT angiography 54 Enlarged prostate 54 dose ionizing radiation 54 R0 resection 54 lymphocytic 54 myelofibrosis polycythemia vera 54 postoperative morbidity 54 prostates